Skip to main content

Vitiligo News

Stigma Affects Quality of Life in Children With Chronic Skin Conditions

TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...

Kids With Common Skin Conditions Face Stigma, Bullying

WEDNESDAY, April 24, 2024 – Acne, psoriasis, eczema, vitiligo, alopecia: Any one of these common skin ailments can render a child vulnerable to stigma and bullying at school, new research confirms....

Health Care Costs, Resource Utilization Increased for Vitiligo Patients

FRIDAY, Feb. 9, 2024 – Patients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of...

Risk for Vitiligo Increased for Transplant Recipients

THURSDAY, Dec. 21, 2023 – Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published...

Half of Patients With Newly Diagnosed Vitiligo Do Not Receive Treatment

TUESDAY, Oct. 17, 2023 – A high proportion of patients with newly diagnosed vitiligo do not receive any treatment, according to a study recently published in Dermatology and Therapy. David Rosmarin,...

COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia

TUESDAY, Oct. 10, 2023 – In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis,...

Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19

TUESDAY, Oct. 10, 2023 – COVID-19 is associated with an increased risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Oct. 6 in JAMA Network...

Reduced Mortality Risk Seen for Patients With Vitiligo

TUESDAY, Sept. 26, 2023 – Patients with vitiligo may have a reduced risk for mortality, according to a study published online Sept. 14 in the Journal of Investigative Dermatology. Hyun Jeong Ju,...

Incidence Rate of Diagnosed Vitiligo 22.6 per 100,000 Person-Years

MONDAY, July 24, 2023 – Vitiligo diagnosis is more common in older adults and in Hispanic/Latino and Asian American patients, according to a study published online July 19 in JAMA Dermatology....

Skin Lightening Prevalent Among 'Skin of Color' Individuals

WEDNESDAY, July 19, 2023 – Among skin of color (SOC) individuals, use of skin lightening (SL), involving the use of chemicals to lighten the skin, is prevalent, and those using SL agents rarely...

Incyte Announces U.S. FDA Approval of Opzelura (ruxolitinib) Cream for the Treatment of Vitiligo

Opzelura is the first and only FDA-approved product for repigmentation in nonsegmental vitiligo Phase 3 data supporting the approval show treatment with Opzelura resulted in improvements in facial...

Ask a question

To post your own question to this support group, sign in or create an account.